Evidence map›Paper›PMID 21098095›Full record

ArticleThe Journal of experimental medicine2010

Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells.

Naoya Takayama, Satoshi Nishimura, Sou Nakamura, Takafumi Shimizu, Ryoko Ohnishi, Hiroshi Endo, Tomoyuki Yamaguchi, Makoto Otsu, Ken Nishimura, Mahito Nakanishi and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 167 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
167citing papers in PubMed, 1 pooled it
12.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

167 citing papers in PubMed, 1 synthesis or guideline pooled it, 345 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Laboratory Assessment and Clinical Outlook forAnnals of laboratory medicine · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Recovery of infectious recombinant human norovirus using zebrafish embryos.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Frontiers in immunology · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. Article

107 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 3 countries.

Naoya TakayamaStem Cell Bank, Center for Stem Cell Biology and Regenerative Medicine, the Institute of Medical Science, Tokyo, Japan.
Satoshi Nishimura
Sou Nakamura
Takafumi Shimizu
Ryoko Ohnishi
Hiroshi Endo
Tomoyuki Yamaguchi
Makoto Otsu
Ken Nishimura
Mahito Nakanishi
Akira Sawaguchi
Ryozo Nagai
Kazutoshi Takahashi
Shinya Yamanaka
Hiromitsu Nakauchi
Koji Eto
Cardiovascular Research Center · BRInstitute for Stem Cell Biology and Regenerative Medicine · INJapan Science and Technology Agency · JPKyoto University · JPThe University of Tokyo · JPNational Institute of Advanced Industrial Science and Technology · JPUniversity of Miyazaki · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human (h) induced pluripotent stem cells (iPSCs) are a potentially abundant source of blood cells, but how best to select iPSC clones suitable for this purpose from among the many clones that can be simultaneously established from an identical source is not clear. Using an in vitro culture system yielding a hematopoietic niche that concentrates hematopoietic progenitors, we show that the pattern of c-MYC reactivation after reprogramming influences platelet generation from hiPSCs. During differentiation, reduction of c-MYC expression after initial reactivation of c-MYC expression in selected hiPSC clones was associated with more efficient in vitro generation of CD41a(+)CD42b(+) platelets. This effect was recapitulated in virus integration-free hiPSCs using a doxycycline-controlled c-MYC expression vector. In vivo imaging revealed that these CD42b(+) platelets were present in thrombi after laser-induced vessel wall injury. In contrast, sustained and excessive c-MYC expression in megakaryocytes was accompanied by increased p14 (ARF) and p16 (INK4A) expression, decreased GATA1 expression, and impaired production of functional platelets. These findings suggest that the pattern of c-MYC expression, particularly its later decline, is key to producing functional platelets from selected iPSC clones.

Indexed as

Gene Expression RegulationAnimalsBlood PlateletsCell Culture TechniquesCell DifferentiationCells, CulturedCyclin-Dependent Kinase Inhibitor p16Flow CytometryHumansInduced Pluripotent Stem CellsMaleMegakaryocytesMiceMice, Inbred NODMice, SCIDMicroscopy, Electron, TransmissionCyclin-Dependent Kinase Inhibitor p16Octamer Transcription Factor-3Platelet Glycoprotein GPIb-IX ComplexPlatelet Membrane Glycoprotein IIbPOU5F1 protein, humanProto-Oncogene Proteins c-mycTumor Suppressor Protein p14ARF

Identifiers

PMID21098095
PMCPMC3005234
OpenAlexW2159714953

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.